{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-18T08:37:33.601032+00:00","published_at":"2026-10-18T07:13:33.900852+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:david-eansor","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"David Eansor","to_label":"Marker Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:6:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:juan-vera","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Juan Vera","to_label":"Marker Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:7:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:katharine-knobil-2","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Katharine Knobil","to_label":"Marker Therapeutics, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:steven-elms","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Steven Elms","to_label":"Marker Therapeutics, Inc.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:katharine-knobil","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Katharine Knobil","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"seat_on","from_id":"alpha:person:kathryn-penkus-corzo","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Kathryn Penkus Corzo","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:audit","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Audit","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:chairs:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11:committee:marker-therapeutics-inc:audit","relationship_type":"chairs","from_id":"alpha:person:david-eansor","to_id":"alpha:committee:marker-therapeutics-inc:audit","from_label":"David Eansor","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11:committee:marker-therapeutics-inc:audit","relationship_type":"member_of","from_id":"alpha:person:kathryn-penkus-corzo","to_id":"alpha:committee:marker-therapeutics-inc:audit","from_label":"Kathryn Penkus Corzo","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:audit-chair-compensation-chair","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Audit · Chair; Compensation · Chair","to_label":"Marker Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5:committee:marker-therapeutics-inc:audit-chair-compensation-chair","relationship_type":"member_of","from_id":"alpha:person:david-eansor","to_id":"alpha:committee:marker-therapeutics-inc:audit-chair-compensation-chair","from_label":"David Eansor","to_label":"Audit · Chair; Compensation · Chair","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:audit-compensation","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Audit; Compensation","to_label":"Marker Therapeutics, Inc.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9:committee:marker-therapeutics-inc:audit-compensation","relationship_type":"member_of","from_id":"alpha:person:steven-elms","to_id":"alpha:committee:marker-therapeutics-inc:audit-compensation","from_label":"Steven Elms","to_label":"Audit; Compensation","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:audit-nominating-and-governance","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Audit; Nominating and Governance","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8:committee:marker-therapeutics-inc:audit-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:kathryn-penkus-corzo","to_id":"alpha:committee:marker-therapeutics-inc:audit-nominating-and-governance","from_label":"Kathryn Penkus Corzo","to_label":"Audit; Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:compensation","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Compensation","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:chairs:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15:committee:marker-therapeutics-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:david-eansor","to_id":"alpha:committee:marker-therapeutics-inc:compensation","from_label":"David Eansor","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15:committee:marker-therapeutics-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:katharine-knobil","to_id":"alpha:committee:marker-therapeutics-inc:compensation","from_label":"Katharine Knobil","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"committee_of","from_id":"alpha:committee:marker-therapeutics-inc:nominating-and-governance","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Nominating and Governance","to_label":"Marker Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:chairs:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19:committee:marker-therapeutics-inc:nominating-and-governance","relationship_type":"chairs","from_id":"alpha:person:katharine-knobil","to_id":"alpha:committee:marker-therapeutics-inc:nominating-and-governance","from_label":"Katharine Knobil","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:member_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19:committee:marker-therapeutics-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:kathryn-penkus-corzo","to_id":"alpha:committee:marker-therapeutics-inc:nominating-and-governance","from_label":"Kathryn Penkus Corzo","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19","evidence_ids":["alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:10:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","relationship_type":"executive_of","from_id":"alpha:person:juan-vera-m-d","to_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","from_label":"Juan Vera, M.D.","to_label":"Marker Therapeutics, Inc.","valid_from":"2026-03-20","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:1ab15c10f9a3a6ab065736efe71018ab3fd589a703b74de56a5e92b362dfd084"]}]},"claims":[{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:5","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-eansor","object_label":"David Eansor","object_source_name_forms":[],"value":"David Eansor: Director, Audit · Chair; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-eansor","name":"David Eansor"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:6","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:juan-vera","object_label":"Juan Vera","object_source_name_forms":[],"value":"Juan Vera: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:juan-vera","name":"Juan Vera"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:7","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:katharine-knobil-2","object_label":"Katharine Knobil","object_source_name_forms":[],"value":"Katharine Knobil: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:katharine-knobil-2","name":"Katharine Knobil"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:8","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathryn-penkus-corzo","object_label":"Kathryn Penkus Corzo","object_source_name_forms":[],"value":"Kathryn Penkus Corzo: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathryn-penkus-corzo","name":"Kathryn Penkus Corzo"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:9","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-elms","object_label":"Steven Elms","object_source_name_forms":[],"value":"Steven Elms: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-elms","name":"Steven Elms"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:leadership_role:10","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:juan-vera-m-d","object_label":"Juan Vera, M.D.","object_source_name_forms":[],"value":"Juan Vera, M.D.: President, Chief Executive Officer, Treasurer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:juan-vera-m-d","name":"Juan Vera, M.D."},"title":"President, Chief Executive Officer, Treasurer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-20","valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:document:1ab15c10f9a3a6ab065736efe71018ab3fd589a703b74de56a5e92b362dfd084","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MRKR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:10.312012+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-20T00:00:00+00:00","effective_from":"2026-03-20","effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:11","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair David Eansor; Members David Eansor (Chair); Kathryn Penkus Corzo; Steven Elms","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"David Eansor","members":[{"display_name":"David Eansor","person_slug":"david-eansor","is_chair":true},{"display_name":"Kathryn Penkus Corzo","person_slug":"kathryn-penkus-corzo","is_chair":false},{"display_name":"Steven Elms","person_slug":"steven-elms","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:15","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair David Eansor; Members David Eansor (Chair); Katharine Knobil; Steven Elms","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"David Eansor","members":[{"display_name":"David Eansor","person_slug":"david-eansor","is_chair":true},{"display_name":"Katharine Knobil","person_slug":"katharine-knobil","is_chair":false},{"display_name":"Steven Elms","person_slug":"steven-elms","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d:committee_record:19","subject_id":"alpha:company:8b0069f3-6f04-4d65-bb6e-21a609e1a45d","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Katharine Knobil; Members Katharine Knobil (Chair); Kathryn Penkus Corzo","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Katharine Knobil","members":[{"display_name":"Katharine Knobil","person_slug":"katharine-knobil","is_chair":true},{"display_name":"Kathryn Penkus Corzo","person_slug":"kathryn-penkus-corzo","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:33.900852+00:00","sources":[{"id":"alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:486798b1dad5ad8feb94c6f5cf41fc4b5e3f918a45540bc621692e70fa693542","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Marker Therapeutics, Inc. DEF 14A 2026-03-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20","retrieved_at":"2026-04-25T00:09:00.467+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1ab15c10f9a3a6ab065736efe71018ab3fd589a703b74de56a5e92b362dfd084","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MRKR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":"2026-03-20T00:00:00+00:00","retrieved_at":"2026-05-16T05:33:10.312012+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:2963726199fb8f167b1f4243859a77c1dee461085e8e678e54fcc0c7bb431027","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926032694/tm261499-3_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.824,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.357},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-18T07:13:33.900852+00:00","observed_at":"2026-10-18T07:13:33.900852+00:00","reviewed_at":"2026-10-18T07:13:33.900852+00:00","verified_at":"2026-10-18T07:13:33.900852+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/marker-therapeutics-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/marker-therapeutics-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}